CVS

NYSE

CVS HEALTH Corp

Latest disclosureJune 29, 2026

Insider score Why 0?: 0/ 100
Qualifying buys · 30d: $0

0 purchases · 9 sales

Price by TradingView

Insider transactions 50

Limited filing history

Filters

Last 30 daysNo qualifying insider buying. No qualifying insider sales.

Showing the first 6 of 9 trades on this page.

Sale disclosed

Larry Robbins

Director

Common Stock

Reported value: $187.33M
Reported price: $94.448 / share

Sale disclosed

Larry Robbins

Director

Common Stock

Reported value: $14.37K
Reported price: $95.18 / share

Sale disclosed

Larry Robbins

Director

Common Stock

Reported value: $74.56M
Reported price: $93.4766 / share

Sale disclosed

Larry Robbins

Director

Common Stock

Reported value: $14.48M
Reported price: $94.8061 / share

Sale disclosed

Larry Robbins

Director

Common Stock

Reported value: $6.4M
Reported price: $95.6655 / share

Sale disclosed

Larry Robbins

Director

Common Stock

Reported value: $77.03K
Reported price: $96.2819 / share

Sale disclosed

Larry Robbins

Director

Common Stock

Reported value: $34.62M
Reported price: $93.4482 / share

Sale disclosed

Larry Robbins

Director

Cash-Settled Swaps

Derivative security · not the ordinary share price.

Reported value: $35.27M
Reported price: $93.311 / derivative unit

Sale disclosed

Tilak Mandadi

EVP, Chief Exp & Tech Officer

Common Stock

Reported value: $6.23M
Reported price: $89.58 / share

Reporting insider	Security / transaction	Amount / price	Value	Traded / disclosed	Source
Director	Common StockSale2 trades	1,983,538avg $94.45 / share	$187.34M	May 19Filed May 21 · 2d later	2 filings 1,983,387 @ $94.45 · $187.33MSEC filing 151 @ $95.18 · $14.37KSEC filing
Director	Common StockSale4 trades	1,018,000avg $93.82 / share	$95.51M	May 20Filed May 21 · 1d later	4 filings 797,628 @ $93.48 · $74.56MSEC filing 152,691 @ $94.81 · $14.48MSEC filing 66,881 @ $95.67 · $6.4MSEC filing 800 @ $96.28 · $77.03KSEC filing
Director	Common StockSale	370,462$93.45 / share	$34.62M	May 21Filed May 21 · 0d later	SEC filing
Director	Cash-Settled SwapsSale	Derivative units378,000$93.31 / derivative unit	$35.27M	May 21Filed May 21 · 0d later	SEC filing
EVP, Chief Exp & Tech Officer	Common StockSale	69,551$89.58 / share	$6.23M	May 8Filed May 11 · 3d later	SEC filing

Congress transactions 9

All Congress filings

Full sale disclosedAmended report

CVS Health Corporation Common Stock · Stock

The filing reports a full sale for a joint account.

Thomas H TubervilleReporting Senate member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: August 26, 2024

Purchase disclosed

CVS Health Corporation Common Stock · Stock

The filing reports a purchase for the member.

AAAlan ArmstrongReporting Senate member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: March 27, 2026

Partial sale disclosedAmended report

CVS Health Corporation Common Stock (CVS) · Stock

The filing reports a partial sale for the member.

Dwight EvansReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: November 21, 2025

Purchase disclosed

CVS Corp · Stock

The filing reports a purchase for a joint account.

John BoozmanReporting Senate member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: January 29, 2026

Sale disclosed

CVS Health Corporation Common Stock (CVS) · Stock

The filing reports a sale for the member.

Dwight EvansReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: November 21, 2025

Sale disclosed

CVS Health Corporation Common Stock (CVS) · Stock

The filing reports a sale for a spouse.

Lisa McClainReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: October 31, 2025

Purchase disclosed

CVS Health Corporation Common Stock (CVS) · Stock

The filing reports a purchase for a spouse.

Lisa McClainReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: October 30, 2025

Sale disclosed

CVS Health Corporation Common Stock (CVS) · Stock

The filing reports a sale for a spouse.

Lisa McClainReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: October 30, 2025

Sale disclosed

CVS Health Corporation Common Stock (CVS) · Stock

The filing reports a sale for a spouse.

Valerie HoyleReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: September 23, 2025

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage

Source: SEC EDGAR · Form 4
Issuer CIK: 0000064803
Latest public acceptance: Jun 29, 2026, 07:11 PM UTC
Score calculated: Oct 8, 2026, 12:03 AM UTC
Parser: form4-parser-1.5
Classifier: form4-classifier-1.1
Scoring methodology: insider-experimental-1.1
Availability: Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.

Reporting insider

Security / transaction

Amount / price

Value

Traded / disclosed

Source

Director

Common StockSale2 trades

1,983,538avg $94.45 / share

$187.34M

May 19Filed May 21 · 2d later

2 filings

1,983,387 @ $94.45 · $187.33MSEC filing
151 @ $95.18 · $14.37KSEC filing

Director

Common StockSale4 trades

1,018,000avg $93.82 / share

$95.51M

May 20Filed May 21 · 1d later

4 filings

797,628 @ $93.48 · $74.56MSEC filing
152,691 @ $94.81 · $14.48MSEC filing
66,881 @ $95.67 · $6.4MSEC filing
800 @ $96.28 · $77.03KSEC filing

Director

Common StockSale

370,462$93.45 / share

$34.62M

May 21Filed May 21 · 0d later

SEC filing

Director

Cash-Settled SwapsSale

Derivative units378,000$93.31 / derivative unit

$35.27M

May 21Filed May 21 · 0d later

SEC filing

EVP, Chief Exp & Tech Officer

Common StockSale

69,551$89.58 / share

$6.23M

May 8Filed May 11 · 3d later

SEC filing

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage

Source: SEC EDGAR · Form 4
Issuer CIK: 0000064803
Latest public acceptance: Jun 29, 2026, 07:11 PM UTC
Score calculated: Oct 8, 2026, 12:03 AM UTC
Parser: form4-parser-1.5
Classifier: form4-classifier-1.1
Scoring methodology: insider-experimental-1.1
Availability: Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.